Neuropsychiatric and neurological diseases in relation to the microbiota-gut-brain axis: From research to clinical care

Metabolomics offers a thorough method for assessing the pathophysiology of complex disorders like depression since it reflects the whole impact of genetic and environmental factors. Amin et al. (2023) conducted this study to analyze the interaction between the human gut microbiota and metabolome in the development of major depressive disorder (MDD), determine the metabolic fingerprints […]

Irritable bowel syndrome (IBS) symptoms have been effectively reduced by treatments that target the gut-brain axis (GBA). People with inflammatory bowel disease (IBD) have much higher rates of common mental illnesses and symptoms similar to IBS, which may indicate that the GBA plays a part in this illness. Manipulating the gut-brain axis could provide new […]